Works matching IS 13479032 AND DT 2020 AND VI 111 AND IP 3
Results: 29
Correction.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 1031, doi. 10.1111/cas.14364
- Publication type:
- Article
Correction.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 1032, doi. 10.1111/cas.14365
- Publication type:
- Article
ALDH1A3‐mTOR axis as a therapeutic target for anticancer drug‐tolerant persister cells in gastric cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 962, doi. 10.1111/cas.14316
- By:
- Publication type:
- Article
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 932, doi. 10.1111/cas.14314
- By:
- Publication type:
- Article
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex‐deficient cancers.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 774, doi. 10.1111/cas.14311
- By:
- Publication type:
- Article
Peptide analogues PKHB1 and 4N1K induce cell death through CD47‐independent mechanisms.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 1028, doi. 10.1111/cas.14310
- By:
- Publication type:
- Article
ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 951, doi. 10.1111/cas.14303
- By:
- Publication type:
- Article
Hospital volume and postoperative 5‐year survival for five different cancer sites: A population‐based study in Japan.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 985, doi. 10.1111/cas.14309
- By:
- Publication type:
- Article
Transcription factor AP‐4 (TFAP4)‐upstream ORF coding 66 aa inhibits the malignant behaviors of glioma cells by suppressing the TFAP4/long noncoding RNA 00520/microRNA‐520f‐3p feedback loop.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 891, doi. 10.1111/cas.14308
- By:
- Publication type:
- Article
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 924, doi. 10.1111/cas.14306
- By:
- Publication type:
- Article
Epstein‐Barr virus‐encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan‐2 and synaptotagmin‐like‐4 in nasopharyngeal carcinoma cells.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 857, doi. 10.1111/cas.14305
- By:
- Publication type:
- Article
Occupational sitting time and subsequent risk of cancer: The Japan Public Health Center‐based Prospective Study.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 974, doi. 10.1111/cas.14304
- By:
- Publication type:
- Article
High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 817, doi. 10.1111/cas.14302
- By:
- Publication type:
- Article
Interstitial chromosomal deletion of the tuberous sclerosis complex 2 locus is a signature for radiation‐associated renal tumors in Eker rats.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 840, doi. 10.1111/cas.14307
- By:
- Publication type:
- Article
Solid‐type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 1008, doi. 10.1111/cas.14301
- By:
- Publication type:
- Article
Dual antivascular function of human fibulin‐3 variant, a potential new drug discovery strategy for glioblastoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 940, doi. 10.1111/cas.14300
- By:
- Publication type:
- Article
Claspin overexpression is associated with high‐grade histology and poor prognosis in renal cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 1020, doi. 10.1111/cas.14299
- By:
- Publication type:
- Article
Significance of the gut microbiome in multistep colorectal carcinogenesis.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 766, doi. 10.1111/cas.14298
- By:
- Publication type:
- Article
Discovery of chemical probes that suppress Wnt/β‐catenin signaling through high‐throughput screening.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 783, doi. 10.1111/cas.14297
- By:
- Publication type:
- Article
Efficient recruitment of c‐FLIP<sub>L</sub> to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 807, doi. 10.1111/cas.14296
- By:
- Publication type:
- Article
TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 881, doi. 10.1111/cas.14295
- By:
- Publication type:
- Article
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 907, doi. 10.1111/cas.14294
- By:
- Publication type:
- Article
Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 795, doi. 10.1111/cas.14293
- By:
- Publication type:
- Article
MicroRNA‐493‐5p‐mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 869, doi. 10.1111/cas.14292
- By:
- Publication type:
- Article
YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 849, doi. 10.1111/cas.14289
- By:
- Publication type:
- Article
P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β‐catenin signaling pathway.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 994, doi. 10.1111/cas.14243
- By:
- Publication type:
- Article
Circulating microRNA‐590‐5p functions as a liquid biopsy marker in non‐small cell lung cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 826, doi. 10.1111/cas.14199
- By:
- Publication type:
- Article
In this Issue: Volume 111, Issue 3, March 2020.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 764, doi. 10.1111/cas.14047
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2020, v. 111, n. 3, p. 761, doi. 10.1111/cas.14046
- Publication type:
- Article